By proceeding, you agree to our Terms of Use and Privacy Policy.
Vice President, Clinical Development, Infectious Diseases
#InfectiousDiseases
#NorthAmerica
Specialties: Clinical Research, Vaccines, Maternal Immunization, Obstetrics & Gynecology.mRNA clearly represents a huge potential for prophylaxis across a wide variety of disease indications, and the
Director of STI Services
#internalmedicine #healthcare #infectiousdiseases #medicaleducation
Aniruddha Hazra serves as the Director of STI Services at the Chicago Center of HIV Elimination. In this pivotal role, Aniruddha leads efforts to address and manage Sexually Transmitted Infections (ST
Chief Scientific Officer, RWS
#epidemiology #infectiousdiseases
Christina’s career at IQVIA has included several leadership roles, all focused on the use of real-world evidence to improve patient care and patient outcomes. Prior to this appointment, Christina serv
CEO & Founder
#Lifesciences #InfectiousDiseases
My 14 years of experience as a senior researcher and executive in the life sciences industry led to the realization that while rare disease drug development was growing, market research solutions for
Infectious Diseases, Professor of Pharmacy
#infectiousdiseases
is a Professor of Pharmacy, an Infectious Diseases Pharmacist, & founding member of the Antimicrobial Stewardship Program (ASP) at The Ohio State University Wexner Medical Center.
Chief Science Officer, OAMD
#genomics #infectiousdiseases #microbiology
Duncan MacCannell is the chief science officer for the CDC’s Office of Advanced Molecular Detection (OAMD), where he helps coordinate the implementation and support of pathogen genomics, bioinformatic
Director Infectious Diseases
#Infectiousdiseases #Research
#Europe
I am appointed to lay out the strategy and lead Vaccibody’s research initiative within infectious diseases.
Professor
#infectiousdiseases #cancer
#Northamerica
Dr. Hans-Peter Kiem is a world-renowned pioneer in stem-cell and gene therapy and in the development of new gene-editing technologies. His focus has been the development of improved treatment and cura
Chief Scientific Officer
#Vaccines #Infectiousdiseases
Biotech executive (MD, PhD Virology, Board Certified Clin Microbiologist, Diploma Trop Med) with very broad experience in immuno-oncology, vaccines, recombinant antibodies and infectious disease R&D,
Chief Executive Officer
#vaccines #infectiousdiseases
Dr. Julie Louise Gerberding is the CEO of the Foundation for the National Institutes of Health (FNIH). Formerly, she was the Chief Patient Officer and Executive Vice President, Population Health and S
Associate Professor Of Medicine
#infectiousdiseases #medicaleducation #molecularbiology
Dr. Justin Bailey is a distinguished medical professional who has carved a notable path in the field of medicine and infectious diseases. His journey began at the University School of Medicine, where
Director of Pandemic Preparedness and Emergency Response
#Vaccine #InfectiousDiseases #CellCulture
Karin Bok is a Senior Advisor for Vaccine and Antibody Development at the Vaccine Research Center, National Institutes of Health where she is providing expertise for the preclinical and clinical devel